ASEPSIS
DEAD

Serial Number

87795063

Owner

Asepsis Medical Technologies, LLC

First Use Date

Nov 25, 2015

Filing Date

Feb 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ASEPSIS Trademark

Serial Number: 87795063 • Registration: 5766826

ASEPSIS is a trademark filed by Asepsis Medical Technologies, LLC on February 12, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Asepsis Medical Technologies, LLC (5 trademarks)

Sarasota, FL 34234

Entity Type: 16

Trademark Details

Filing Date

February 12, 2018

Registration Date

June 4, 2019

First Use Anywhere

November 25, 2015

First Use in Commerce

November 25, 2015

Published for Opposition

March 19, 2019

Cancellation Date

December 19, 2025

Goods & Services

Injectable, oral and topical pharmaceutical preparations, namely, anti-infectives, antibacterial pharmaceuticals, antifungal medications, antibiotics, antivirals, antiemetics, analgesics for treating asthma, arthritis treatment preparations, antitussives, anesthetics, cardiovascular treatment preparations, cold and flu prevention and treatment preparations, dermatologicals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, decongestants, diluents for reconstitution of medications, homeopathic supplements, antipyretic preparations, ocular and intraocular pharmaceuticals, steroids, corticosteroids, hormones, dermatologicals, pharmaceutical preparations for use in hematology, intravenous fluid used for rehydration, nutrition and the delivery of pharmaceutical preparations, rehydration treatment preparations, nutritional supplements, anti-allergic pharmaceutical preparations and substances, pharmaceutical preparations acting on the central nervous system, gastro-intestinal treatment preparations, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical agents affecting metabolism, pharmaceutical products for treating respiratory diseases, pharmaceutical preparations for treatment of musculo-skeletal disorders, anti-inflammatories, pharmaceutical preparations for the prevention and treatment of osteoporosis, pharmaceutical preparations for use in organ transplantation, pharmaceutical preparations for the prevention and treatment of infectious diseases; diluent syringes sold filled with diluent solutions for medical purposes; diluent containers sold filled with diluent solutions for medical purposes; reconstitution agents and solutions for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 19, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 4, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2019 NONP
ASSIGNED TO LIE
Feb 11, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2019 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 3, 2018 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 3, 2018 PARI
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2018 CNRT
ASSIGNED TO EXAMINER
May 25, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 22, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2018 NWOS
NEW APPLICATION ENTERED
Feb 15, 2018 NWAP